Coronavirus is spreading continuously all over the world. Over 2 million people have been infected from this deadly virus, and there’s no cure available. Scientists are working on the vaccine for the virus but this may take time. Meanwhile, there’s a technique by which the treatment of coronavirus is possible. Yes, there’s a method that can be used for the treatment of coronavirus. It is known as Convalescent Plasma Therapy. But, first we need to know that What is Plasma? What is Convalescent Plasma Therapy? Let’s find out.
What is Plasma?
Plasma is that liquid part of the blood which contains antibodies. The main role of plasma is to take nutrients, hormones, and proteins to the parts of the body that require it. Plasma contains important components which include antibodies, clotting factors, and also the proteins albumin and fibrinogen.
What is Plasma Therapy?
Plasma Therapy aims at using antibodies from the blood donated by the recovered patients to treat those who are under treatment. It can also be used to make people immune who are at high risk of contracting the virus such as health workers, families of patients, etc. The main concept of this therapy is based on the assumption that the blood of a patient who has recovered from COVID-19 contains antibodies with the specific ability of fighting novel coronavirus.
Is plasma therapy working for COVID-19?
According to researchers, it is a preventive measure and not a treatment for the COVID-19 disease but it can save a lot of lives. One can donate blood only if they have been symptom-free for 28 days and have tested negative twice. The potential of this therapy for the treatment of corona has already been explored in limited trials in China. The trial showed some improvement in the patients’ condition. This therapy can work wonders if done carefully. Risks involved in this therapy are as follows:
- It can affect the immune system of the body.
- Blood transfusion can happen which may result in infection.
Plasma Therapy in India
Indian Council of Medical Research (ICMR) has invited a Letter of Intent (LoI) for participation in studies to validate the Therapeutic Plasma Exchange (TPE). It is an experimental procedure to treat critically ill coronavirus patients. Kerala is the first state in India to start using this plasma therapy. Kerala started doing the research and protocols for plasma therapy even before the US Food and Drug Administration (FDA) approved it on April 3.
You May Also Like: Coronavirus symptoms: 5 Coronavirus tips you should keep in mind